September 14, 2021
The Gilbert Family Foundation is excited to announce a $5.4 million study to understand the mechanisms of vision loss caused by NF1-associated optic pathway gliomas, or NF1-OPGs. Led by Drs. Robert Avery (CHOP) and Jeffrey Goldberg (Stanford), findings are expected to inform the development of future therapies, validate existing models of the disease, and help identify new metrics for evaluating the efficacy of vision restoration treatments.
July 15, 2021
The Gilbert Family Foundation (GFF) announced the launch of a clinical study that aims to validate optical coherence tomography (OCT) as a tool to objectively assess the visual system and its response to treatment in NF1 patients with optic pathway gliomas.
May 20, 2021
The Gilbert Family Foundation (GFF) is excited to announce the development of a database for neurofibromatosis type 1 (NF1) research tools in collaboration with Sage Bionetworks. The database aims to support the development of a robust NF1 research toolkit while also lowering the barrier of entry to research for new-to-NF1 investigators. GFF and Sage intend the database to be used by a variety of stakeholders in the NF1 research community, including researchers, drug developers, and research funders.
March 24, 2021
DETROIT, March 25, 2021 – The Gilbert Family Foundation (GFF) and Rocket Community Fund today announced an unprecedented and transformational $500 million philanthropic investment over the next ten years, to be accomplished through strategic contributions to community organizations that will build economic opportunity in Detroit neighborhoods. The Gilbert Family Foundation will contribute $350 million, and […]